Clerkenwell Health Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

2020

Location

London UK

Primary Industry

Healthcare

About

Based in London, UK, and founded in 2020, Clerkenwell Clinics Limited, doing business as Clerkenwell Health, operates as a mental health company that provides psychedelic-specialist CRO (contract research organization) services such as psychedelic-drug clinical trials, and trial management for its clients. The company was co-founded by Thomas Mcdonald (CEO), Sam Lewis (CFO), and Henry Fisher (CSO), and in October 2022, Clerkenwell Health raised GBP 2.1 million in seed funding from Convergence Partners and Exceptional Ventures, with participation from Lionheart Ventures. The firm offers a wide range of bespoke services including clinical trial design, scientific and regulatory advisory, clinical trial delivery (through a state-of-the-art facility), trial monitoring and management, etc., primarily for psychedelic drug manufacturers to help them accelerate the drug development process ranging from phase I to III trials to FDA approval and market launch. The company also conducts clinical trials for any conditions that the clients are interested in studying. Clerkenwell Clinics Limited’s in-house team comprises clinical trial managers, scientists, psychiatric, and psychedelic specialists, etc. The company intends to use the October 2022 funding to make its London facility fully operational.

Current Investors

Solcon Capital, Lionheart Ventures, Exceptional Ventures

Request a demo to show more

Primary Industry

Healthcare

Sub Industries

Clinics/Outpatient Services, Mental Health Services

Website

www.clerkenwellhealth.com

Company Stage

Angel & Seed

Total Amount Raised

Subscriber access only

Employee Data

Want to see the Employee Count?

Request a demo for full access to this profile.

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.